Weight loss drug is not taking easy way out

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...
With weight loss drugs like metformin and Ozempic gaining popularity, it's essential to understand how they compare. So we ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...
GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.